Ontology highlight
ABSTRACT: Background and objectives
Statins are less efficacious in reducing cardiovascular disease risk in patients on dialysis than in the general population. Recent experimental data showed that phosphate excess promotes cellular de novo cholesterol synthesis through 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase activation. Whether this mechanism might account for the resistance of patients on dialysis to statins has not yet been explored.Design, setting, participants, & measurements
In this post hoc analysis, we examined the efficacy of statin treatment according to serum phosphate levels in the patients on dialysis who were participants of the A Study to Evaluate the Use of Rosuvastatin in Subjects on Regular Hemodialysis: An Assessment of Survival and Cardiov
SUBMITTER: Massy ZA
PROVIDER: S-EPMC8993469 | biostudies-literature | 2022 Apr
REPOSITORIES: biostudies-literature